Alembic Share price

Q: How to buy Alembic Share at Choice?

To buy Alembic stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic, choose your preferred order type, and place the trade.

ALEMBICLTD

Real Estate Mid Cap

87.12

1.12 (1.30%)

NSE

BSE

Last updated on 5 Jun, 2026 | 15:47 IST

BuySell

Today's High

88.40

Today's Low

86.10

52 Week Low

0.00

52 Week High

88.40

Alembic Chart

ChartIQ

TradingView

Alembic Share Key Metrics

Volume

3.26 L

Market Cap

2237.08 CR

LTQ@LTP

2@87.12

ATP

87.41 Var Margin

17.46 %

Circuit Range

68.8-103.2

Delivery %

- %

Value

2.85 CR

ASM/GSM

No

Market Lot

1

Summary

Alembic share price is ₹87.12 as of 5 Jun, 2026. The stock Alembic intraday movement has stayed between ₹86.10 and ₹88.40, while on a 52-week basis,Alembic price 52 week high is ₹88.40 & its 52 week low is ₹0.00.

In terms of trading activity, Alembic has recorded a volume of 326110 shares, The Alembic has a market cap of ₹256781828 CR. The stock’s Average Traded Price (ATP) stands at ₹87.41, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2 @ ₹87.12.

Alembic operates within a circuit range of ₹68.80 – ₹103.20, with a Value of ₹2.85 CR. The Delivery Percentage for the day is -1%. Additionally, Alembic currently falls under the No framework, and trades with a market lot size of 1.

Alembic Fundamentals

P/E Ratio

6.96

P/B Ratio

0.96

Div. Yield

2.79

Sector P/E

62.76

Sector P/B

2.98

Sec. Div. Yield

0.18

Alembic Resistance and Support

Pivot 86.01

Resistance

First Resistance

86.95

Second Resistance

87.89

Third Resistance

88.83

Support

First Support

85.07

Second Support

84.13

Third Support

83.19

Alembic Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

70.88%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.25%

Domestic Institutional Investors

0.04%

Retail

27.83%

Others

0%

Total Promoters

MAR '26

70.88%

Alembic Corporate Actions

Date	Agenda
2026-05-19	Audited Results & Final Dividend
2026-02-12	Quarterly Results
2025-11-10	Quarterly Results
2025-08-12	Quarterly Results & Other
2025-05-13	Audited Results & Final Dividend
2025-02-07	Quarterly Results & Other

Alembic News

Alembic Pharma gets USFDA nod for Tourette's Disorder treatment drug

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Haloperidol Tablets USP, in multiple strengths. This generic drug is indicated for the treatment of psychotic disorders and Tourette's disorder, marking a new product launch opportunity for the company.

Jun 05 2026 12:16:57

Alembic Limited

Alembic Limited's Board recommended a final dividend of Rs.2.4 per equity share for FY2025-26. The record date for the dividend is August 4, 2026, and the payment is expected by September 10, 2026, post AGM approval on August 11, 2026.

May 19 2026 18:14:56

Alembic Ltd - 506235 - Board Meeting Outcome for Outcome Of The Board Meeting

Alembic's board approved Q4 FY26 consolidated net profit of ₹9.61 crore, marking a 59.5% YoY decline. For the full year FY26, consolidated net profit decreased by 12.9% to ₹125.93 crore, despite an 8.2% increase in total revenue to ₹239.99 crore. The company also recommended a final dividend of ₹2.40 per equity share for FY26.

May 19 2026 17:55:13

Alembic Pharma Q4 profit up 29% as US formulations business grows 11%; declares ₹12 dividend

Alembic Pharma reported a 29% year-on-year increase in its Q4 net profit, driven by an 11% growth in its US formulations business. The company also declared a final dividend of ₹12 per equity share for the financial year ended March 31, 2026.

May 15 2026 15:53:10

Alembic Pharma shares rise on USFDA nod for prostate cancer drug with $3 billion estimated market size

Alembic Pharmaceuticals has received USFDA tentative approval for its Darolutamide Tablets, 300 mg, a prostate cancer medication that is therapeutically equivalent to Bayer's Nubeqa. This approval targets an estimated US$3.155 billion market for the twelve-month period ending March 2026, contingent upon the expiry of patent protections or exclusivity periods.

May 14 2026 11:24:11

Alembic Ltd - 506235 - Board Meeting Intimation for Considering Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2026

Alembic Limited's Board of Directors will hold a meeting on May 19, 2026. The agenda includes considering and approving the audited financial results for the quarter and financial year ended March 31, 2026, and recommending a dividend on Equity Shares.

May 08 2026 12:52:54

Name	Position
Chirayu Amin	Chairman
Rati Desai	Non Executive Independent Director

Alembic Similar Stocks

Kolte-Patil Developers Ltd.

362.10

-2.90 (0.79%)

Hubtown Ltd.

203.30

0.71 (0.35%)

Marathon Nextgen Realty Ltd.

408.90

-9.45 (2.26%)

Elpro International Ltd.

167.74

-0.15 (0.09%)

Arvind Smartspaces Ltd.

584.60

0.20 (0.03%)

Ajmera Realty & Infra India Ltd.

121.67

3.01 (2.54%)

Arkade Developers Ltd.

112.63

-0.59 (0.52%)

Capacit'e Infraprojects Ltd.

222.09

-5.15 (2.27%)

Garuda Construction & Engineering Ltd.

167.23

-3.15 (1.85%)

Shriram Properties Ltd.

88.18

-0.29 (0.33%)

Alembic FAQs

The Buying Price of Alembic share is 87.12 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Alembic stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Alembic shares is 6.96. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Alembic shares is 0.96. Useful to assess the stock's value relative to its book value.

To assess Alembic’s valuation compare Sector P/E, P/B which are 62.76 & 2.98 with sector averages, along with growth rates and financial metrics.

The Market Cap of Alembic is 2237.08 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Alembic share price is 88.40 & 0.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Alembic belongs to the Real Estate sector.